Loading organizations...

§ Venture Capital · Trenton, NJ, USA
venture capital firm investing in early-stage technology companies, commercializing IP from national labs and universities.
Battelle Ventures operates as a venture capital firm, strategically aligned with the Battelle Memorial Institute, focused on advancing the commercialization of technology. The firm provides early-stage capital and strategic support to emerging companies working with innovations spanning various scientific and engineering disciplines. Its approach emphasizes translating foundational research into viable market solutions, leveraging deep technical insights to foster growth.
Established in 2003, Battelle Ventures emerged as an extension of Battelle’s longstanding commitment to scientific discovery and its practical application. The firm was conceived from the insight that a dedicated investment vehicle could bridge the gap between groundbreaking laboratory innovations and their successful market entry. This initiative harnessed Battelle's extensive research and development heritage to identify and nurture promising ventures.
The firm's focus was on technology-driven companies poised to address significant industry challenges. Battelle Ventures aimed to empower entrepreneurs with both financial resources and the institutional knowledge necessary to scale their innovations. Its overarching vision centered on accelerating the development and deployment of next-generation technologies that would create lasting societal and economic impact.
Battelle Ventures has 8 tracked investments across 3 companies. The latest tracked deal is $53.0M Series C in Bionano Genomics in November 2014.